These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21013836)

  • 1. Erythroblastosis fetalis and the rhesus factor.
    SALZMAN W
    Chic Med Sch Q; 1945; 6(3):17. PubMed ID: 21013836
    [No Abstract]   [Full Text] [Related]  

  • 2. The rhesus problem.
    FOLAN ME; O'DRISCOLL D; MCNICHOLL B
    J Ir Med Assoc; 1956 Jan; 38(223):9-14. PubMed ID: 13278610
    [No Abstract]   [Full Text] [Related]  

  • 3. The rhesus factor (part 2).
    DUNDON S; O'DRISCOLL K; GEOGHEGAN F
    J Ir Med Assoc; 1952 Mar; 30(177):65-9. PubMed ID: 14927994
    [No Abstract]   [Full Text] [Related]  

  • 4. The rhesus factors; haemolytic disease of the new-born.
    CORNER BD
    Bristol Med Chir J (1883); 1947; 64(231):74-80. PubMed ID: 18901978
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis and therapy of isoimmunization to the rhesus factors--personal contribution].
    CIMBERLE E
    G Veneto Sci Med; 1961; 16():577-85. PubMed ID: 13879540
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical, haematological and serological symptoms in the newborn child suffering from hemolytic disease of the newborn due to Rhesus-antagonism.
    SOETERS JM
    Maandschr Kindergeneeskd; 1950; 18(3/4):160-4. PubMed ID: 15438073
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythroblastosis models. A review and new experimental data in monkeys.
    Wiener AS; Socha WW; Niemann W; Moor-Jankowski J
    J Med Primatol; 1975; 4(3):179-87. PubMed ID: 808623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythroblastosis fetalis. I. Problems in the interpretation of changing mortality in erythroblastosis fetalis.
    VAUGHAN VC; ALLEN FH; DIAMOND LK
    Pediatrics; 1950 Aug; 6(2):173-82. PubMed ID: 14776002
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal models of mechanisms of erythrocyte destruction: why aren't the erythrocytes of the newborn rhesus monkey (Macaca mulatta) destroyed by maternal antibodies?
    Stone WH; Stong R; Blazkovec A; Blystad C; Houser WD
    Prog Clin Biol Res; 1980; 43():237-49. PubMed ID: 7422687
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis and therapy of erythroblastosis fetalis due to Rhesus antagonism].
    HART PG; HOYNCK VAN PAPENDRECHT HP
    Ned Tijdschr Geneeskd; 1961 May; 105():929-37. PubMed ID: 13711883
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma pigments in erythroblastosis fetalis. II. The level of heme pigment; an early guide to management of erythroblastosis fetalis.
    BOGGS TR; ABELSON NM
    Pediatrics; 1956 Apr; 17(4):461-70. PubMed ID: 13310079
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies in erythroblastosis fetalis; investigations on the detection of sensitization of the red blood cells of newborn infants with erythroblastosis fetalis.
    WITEBSKY E; RUBIN MI
    J Lab Clin Med; 1947 Nov; 32(11):1339-49. PubMed ID: 18917893
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythroblastosis fetalis produced by Kell immunization: dental findings.
    Cullen CL
    Pediatr Dent; 1990; 12(6):393-6. PubMed ID: 2087415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of severe erythroblastosis fetalis (fetal hydrops) with recovery.
    FRANKOWSKI C
    J Am Med Womens Assoc; 1957 Aug; 12(8):259-61. PubMed ID: 13462880
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythroblastosis fetalis due to the Kell factor.
    ARENDS NW
    J Am Osteopath Assoc; 1957 Jan; 56(5):305-7. PubMed ID: 13385178
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythroblastosis fetalis in the first-born; prevention of its most severe forms.
    LEVINE P; WALLER RK
    Blood; 1946 Mar; 1():143-55. PubMed ID: 21015977
    [No Abstract]   [Full Text] [Related]  

  • 17. Nursing care of the infant with erythroblastosis fetalis.
    Hill AS; Cochran CK; Dickerson C
    J Pediatr Nurs; 1989 Dec; 4(6):395-402. PubMed ID: 2689631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of congenital hemolytic disease (erythroblastosis fetalis); theoretic considerations.
    WIENER AS
    Am J Dis Child (1911); 1946 Jan; 71():14-24. PubMed ID: 21018125
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in prognosis and treatment of erythroblastosis fetalis.
    PENDER PF
    Bull Utica Acad Med; 1947 Nov; 12(9):132-7. PubMed ID: 20271124
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemolytic anemia of the newborn (erythroblastosis fetalis) report of cases.
    ALEMAN RG
    New Orleans Med Surg J; 1945 Dec; 98():278-80. PubMed ID: 21006236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.